Non-receptor tyrosine kinase

Results: 28



#Item
1ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced

ZAI Lab and Hanmi execute a license agreement to develop novel EGFR targeted therapy for lung cancer in China Shanghai, China and Seoul, Korea, 23th November 2015 – ZAI Lab Limited and Hanmi Pharm. Co., Ltd. announced

Add to Reading List

Source URL: www.zailaboratory.com

Language: English - Date: 2015-11-24 01:50:17
2PRESS RELEASE  Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

Add to Reading List

Source URL: www.oncodesign.com

Language: English - Date: 2016-07-12 12:51:48
3M i ch a e l P h am 5019 Frink Ave| San Diego, CA 92117| ( |  Accomplishments Identification and confirmation of Janus Kinase 2 (Jak2) directly phosphorylating metabolic regulator kina

M i ch a e l P h am 5019 Frink Ave| San Diego, CA 92117| ( | Accomplishments Identification and confirmation of Janus Kinase 2 (Jak2) directly phosphorylating metabolic regulator kina

Add to Reading List

Source URL: venturabiocenter.com

Language: English - Date: 2015-12-25 20:40:07
405-AUG:10 LUNG ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

05-AUG:10 LUNG ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

Add to Reading List

Source URL: www.swogstat.org

Language: English - Date: 2016-08-19 21:10:12
5Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD  April 17th, 2016

Blood Testing for EML4-ALK Fusion Transcripts in Non-Small Cell Lung Cancer Patients by ddPCR: A CLIA Lab Experience Hestia Mellert, PhD April 17th, 2016

Add to Reading List

Source URL: www.biodesix.com

Language: English - Date: 2016-05-02 01:40:22
6CURRICULUM VITAE  1. Name: SHAO-CHUN WANG Title and Affiliation: Investigator and Deputy Director China Medical University Hospital

CURRICULUM VITAE 1. Name: SHAO-CHUN WANG Title and Affiliation: Investigator and Deputy Director China Medical University Hospital

Add to Reading List

Source URL: cancerbio.cmu.edu.tw

Language: English - Date: 2016-01-19 03:59:58
7Technology Opportunity, Ref. No. UZNovel nanomolar inhibitor of Eph tyrosine kinases New small molecule inhibitors of Eph kinases have been developed which have potential therapeutic application in angiogenesis

Technology Opportunity, Ref. No. UZNovel nanomolar inhibitor of Eph tyrosine kinases New small molecule inhibitors of Eph kinases have been developed which have potential therapeutic application in angiogenesis

Add to Reading List

Source URL: www.switt.ch

Language: English - Date: 2014-02-01 16:41:28
8CrossMark_Color_Stacked_p

CrossMark_Color_Stacked_p

Add to Reading List

Source URL: www.biochem-caflisch.uzh.ch

Language: English - Date: 2014-08-22 09:07:41
9Optimization of Dosing for EGFR-Mutant Non−Small Cell Lung Cancer with Evolutionary Cancer Modeling Juliann Chmielecki, et al. Sci Transl Med 3, 90ra59 (2011); DOI: scitranslmed

Optimization of Dosing for EGFR-Mutant Non−Small Cell Lung Cancer with Evolutionary Cancer Modeling Juliann Chmielecki, et al. Sci Transl Med 3, 90ra59 (2011); DOI: scitranslmed

Add to Reading List

Source URL: michorlab.dfci.harvard.edu

Language: English - Date: 2011-08-23 09:57:30
10· Non-Small Cell Lung Cancer ·  Antiangiogenesis and Future Combinations with Anti-Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer Edward S. Kim, MD

· Non-Small Cell Lung Cancer · Antiangiogenesis and Future Combinations with Anti-Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer Edward S. Kim, MD

Add to Reading List

Source URL: gotoper-com.s3.amazonaws.com

Language: English - Date: 2015-09-10 13:42:25